Holen Sie sich die Stockscreener-App
19.64
7.84%
-1.67
Handel nachbörslich:
19.39
-0.25
-1.27%
Schlusskurs vom Vortag:
$21.31
Offen:
$21.15
24-Stunden-Volumen:
5.78M
Relative Volume:
2.02
Marktkapitalisierung:
$4.99B
Einnahmen:
$426.45M
Nettoeinkommen (Verlust:
$197.67M
KGV:
23.95
EPS:
0.82
Netto-Cashflow:
$110.10M
1W Leistung:
-6.07%
1M Leistung:
-0.81%
6M Leistung:
+25.74%
1J Leistung:
+213.24%
1-Tages-Spanne:
$18.80
$21.59
1-Wochen-Bereich:
$18.80
$22.25
52-Wochen-Spanne:
$6.19
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
19.64 | 4.99B | 426.45M | 197.67M | 110.10M | 0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
How to Take Advantage of moves in (ADMA) - news.stocktradersdaily.com
Adma Biologics (ADMA) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
ADMA Biologics (ADMA): Among Louis Navellier’s New Stock Picks - Yahoo Finance
Adma Biologics CEO Adam Grossman sells $450,660 in stock By Investing.com - Investing.com Canada
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? - MSN
Why ADMA Biologics, Inc. (ADMA) Skyrocketed On Tuesday? - Insider Monkey
10 Firms End Stronger on Tuesday - Insider Monkey
Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average - Zacks Investment Research
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Adma Biologics (ADMA) Moves 7.8% Higher: Will This Strength Last? - Yahoo Finance
Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Why ADMA Biologics Inc. (ADMA) Skyrocketed On Monday? - Insider Monkey
Biotech Stocks Dominate Monday’s Top 10 Gainers - Insider Monkey
Axogen and ADMA Biologics expect low to zero impact from recent tariffs - MSN
ADMA Biologics says tariffs will not impact operations due to fully U.S.-based supply chain - ROI-NJ
Does Adma Biologics (ADMA) Have the Potential to Rally 51.75% as Wall Street Analysts Expect? - MSN
Sector Update: Health Care - MarketScreener
ADMA Biologics Says Tariffs Not Likely to Impact Supply Chain, Production Operations - MarketScreener
Adma BiologicsTariffs Expected To Have No Impact On Adma's Operations - MarketScreener
ADMA Biologics Statement on Tariffs - GlobeNewswire
ADMA's All-American Operations Shield Company From New Tariff Storm - Stock Titan
Wall Street Analysts Predict a 39.08% Upside in Adma Biologics (ADMA): Here's What You Should Know - MSN
Trading (ADMA) With Integrated Risk Controls - news.stocktradersdaily.com
Ensign Group Invests in Growth With New Facility Acquisitions - TradingView
ADMA STOCK DROP ALERT: ADMA Biologics, Inc. Stock Drops over 20%; BFA Law Initiates Securities Fraud Investigation and Urges Investors with Losses to Contact the Firm (Nasdaq:ADMA) - ACCESS Newswire
What's Driving the Market Sentiment Around ADMA Biologics? - Benzinga
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest? - Yahoo Finance
Adma Biologics (ADMA) Stock Moves -0.15%: What You Should Know - Yahoo Finance
How IBD Stock Of The Day ADMA Biologics Shrugged Off Accounting Debacle For A Bullish Comeback - MSN
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research
Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains? - MSN
Adma Biologics CEO Adam Grossman sells $397,320 in stock By Investing.com - Investing.com Australia
Adma Biologics CEO Adam Grossman sells $397,320 in stock - Investing.com
Here is What to Know Beyond Why ADMA Biologics Inc (ADMA) is a Trending Stock - Yahoo Finance
ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential - Seeking Alpha
ADMA Stock Builds A Base As Profits Continue To Soar - MSN
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Pulse of the Market: Wednesday’s 10 Top Performers - Insider Monkey
Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus
Why ADMA Biologics Inc. (ADMA) Went Up On Wednesday? - Yahoo Finance
Why Adma Biologics (ADMA) Outpaced the Stock Market Today - MSN
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):